Choosing Wisely Africa

Adding atezolizumab to adjuvant chemotherapy for stage II and III triple-negative breast cancer is unlikely to improve efficacy

The human inside oncology

Conflicts of interest in oncology

T-DM1 shows promise in treating unresectable locally advanced or metastatic HER2-positive breast cancer

ASCO and its Sub-Saharan African outreach programme

The Common Sense movement in Oncology

CDK-4/6 inhibitors with endocrine treatment for metastatic breast cancer

Implementation Science: An emerging role for strengthening cancer control efforts in Africa

Implementation of Choosing Wisely in Rwanda, Tanzania and Ghana

The BIG Cat Initiative in Africa

The quantification of cancer medicines in Zambia